Bayer AG is pushing ahead with its efforts to fend off alleged attempts to infringe on patents of some of its key products in India.
Bayer Seeks To Ward Off Xarelto Infringers In India
Bayer presses on with legal action to fend off alleged infringers of its patent on Xarelto in India. A hearing is expected shortly in one such case, which seemingly includes a settlement option. The German multinational also remains engaged in a keenly contested and controversial case around India’s Bolar exemption provision - the experimental use or early working exception.
